Back to Search
ANN TRAYNOR, M.D.
M.D.
Internal Medicine Physician
NPI: 1831171768Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
TD061073(ME)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301104227(MI)
Research & Publications (20)
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
PMID 19238328·Invest New Drugs·2010
3-trial
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.
PMID 19434370·Invest New Drugs·2010
3-trial
A pharmacy course on leadership and leading change.
PMID 19513161·Am J Pharm Educ·2009
4-observational
Student leadership retreat focusing on a commitment to excellence.
PMID 19564991·Am J Pharm Educ·2009
8-other
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
PMID 18841362·Cancer Chemother Pharmacol·2009
3-trial
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
PMID 18701186·Lung Cancer·2009
8-other
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
PMID 18941749·Cancer Chemother Pharmacol·2009
4-observational
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
PMID 19082825·Cancer Chemother Pharmacol·2009
3-trial
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
PMID 19347984·J Thorac Oncol·2009
3-trial
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.
PMID 18451239·Clin Cancer Res·2008
3-trial
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
PMID 18640937·J Clin Oncol·2008
3-trial
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
PMID 18758305·J Thorac Oncol·2008
3-trial
Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation.
PMID 18326564·Nephrol Dial Transplant·2008
5-case
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study.
PMID 19044323·Technol Cancer Res Treat·2008
3-trial
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.
PMID 18061679·J Inorg Biochem·2008
8-other
Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
PMID 17277794·Bone Marrow Transplant·2007
3-trial
Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.
PMID 17483845·Bone Marrow Transplant·2007
8-other
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.
PMID 17409860·J Thorac Oncol·2006
3-trial
Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
PMID 17409930·J Thorac Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
3.8(218)
- Address
- 261 M 62
CASSOPOLIS, MI 49031 - Phone
- (269) 445-3874
- Website
- cassfamilyclinic.org
3.8(218)
See full reviewsQuick Facts
- NPI
- 1831171768
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile